Important changes in pharmacies come into effect on April 1
Starting April 1, 2026, Poland's Ministry of Health will implement significant updates to the list of reimbursed medications, introducing 16 new therapies, primarily for cancer and rare diseases.
Cancer Medicine: The Biohackers in My Body
The article discusses recent findings in cancer medicine, highlighting how cancer cells interact intricately with the nervous system, potentially leading to new therapies.
Combination Therapy Using Anti-Cancer New Drugs Raises Concerns About Collusion, Impeding Insurance Coverage
Despite a paradigm shift towards combination therapies using new cancer drugs, challenges in insurance coverage persist due to regulatory obstacles and concerns about collusion among pharmaceutical companies.
Communication, diagnostics, therapies β how to treat bladder cancer more effectively
The article discusses the importance of communication, diagnostics, and therapies in the effective treatment of bladder cancer in Poland.
Communication, diagnostics, therapies - how to treat bladder cancer more effectively
Bladder cancer is a significant health concern in Poland, ranking as the fourth most common malignancy among men, prompting discussions on improving diagnostic and therapeutic strategies.
Biotechnology: The departure of the founders is a disaster for Biontech
The stock price of Biontech plummeted by about 20% following the announcement of founders UΔur Εahin and Γzlem TΓΌreci stepping back from the company by the year's end.
New Gastrointestinal Therapies: How AI Can Help Cancer Doctors
Experts report significant advancements in personalized treatment for gastrointestinal tumors, with AI promising improvements in early detection.
New Gastrointestinal Therapies: How AI Can Help Cancer Doctors
Medical professionals report significant progress in personalized treatment for gastrointestinal tumors, with digital assistance promising to enhance early detection.
Why is the wait for innovative cancer drugs particularly long in Korea?
Despite advancements in cancer treatment technologies, South Korean patients face significantly longer wait times for new cancer drugs compared to other developed countries.
Michel Sadelain, one of the fathers of CAR-T, the promising therapies against cancer: "They are living medications that multiply within the patient's body"
Michel Sadelain, a key figure in CAR-T therapy, discusses the advancements in cancer treatment and the ongoing challenges in targeting solid tumors.
Trained defenses attack the 'castle' of solid tumors: CAR-T therapies find weaknesses in the kidney, ovary, and pancreas
Recent advances in CAR-T therapy show potential for effectively targeting solid tumors in organs such as the kidney, ovary, and pancreas, addressing a significant challenge in cancer treatment.
When standard treatment no longer helps: advanced cancer diagnostics and treatment at Kaunas Clinics
The Kaunas Clinics have launched a Nuclear Medicine Research Center, offering modern treatments for advanced cancer through precision medicine and innovative therapies.
The parents of CAR T therapies against cancer receive the BBVA Foundation Frontiers of Knowledge Award in Biomedicine
Researchers Carl June and Michel Sadelain have been awarded the BBVA Foundation Frontiers of Knowledge Award in Biomedicine for their pioneering work in CAR-T cell therapies that transform cancer treatment.
βCancer treatment incurs costsβ: Oncological therapies harm survivors' hearts
Cancer treatments can lead to heart damage in survivors, as observed in cases like that of a policeman treated for non-Hodgkin lymphoma.
Broccoli, Fasting, Sugar Reduction β the Influence of Nutrition in Cancer
Expert Jann Arends discusses the potential of diet in preventing cancer and supporting therapies, based on decades of experience in clinical nutritional medicine in oncology.
Unveiling why some cancer therapies increase cardiac risk
Research reveals that clonal hematopoiesis, characterized by age-related variants in blood stem cells, may explain the increased cardiac risk in certain cancer therapies.
The public health system spends tens of millions of euros on unnecessarily high doses of cancer therapies
Spain's public health system incurs annual expenses of tens of millions of euros on excess doses of popular cancer immunotherapies, as pharmaceutical companies persuade regulatory bodies to standardize treatment based on inflated weight assumptions.
"We already have many effective tools": the promises of personalized therapies against cancer
The article discusses the advancements in technology leading to personalized cancer therapies amid rising cancer diagnoses in France.
Medicine in 2026: Developments Changing Diagnosis and Treatment
The article discusses significant advancements in medicine expected by 2026, including artificial intelligence, personalized gene therapies, and major cancer screening tests.
The medicine cabinet for 2026: Ozempic's 'pill', multiple cancer therapies, and news in inflammatory pathologies
The article discusses the anticipated developments of leading drugs in 2026, focusing on GLP-1 agonists, new multi-target compounds, and advancements in treatments for obesity and diabetes, along with their expanding applications in other health conditions.